ScholarIQanswers from OpenAlex

Efficacy of Immune Checkpoint Inhibitors in Lung Sarcomatoid Carcinoma

PaperCitations, authors & open-access status

Efficacy of Immune Checkpoint Inhibitors in Lung Sarcomatoid Carcinoma is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Efficacy of Immune Checkpoint Inhibitors in Lung Sarcomatoid Carcinoma have?

ScholarIQcitation count

Efficacy of Immune Checkpoint Inhibitors in Lung Sarcomatoid Carcinoma has 137 citations in the OpenAlex counts ScholarIQ stores.

When was Efficacy of Immune Checkpoint Inhibitors in Lung Sarcomatoid Carcinoma published?

ScholarIQyear

Efficacy of Immune Checkpoint Inhibitors in Lung Sarcomatoid Carcinoma has 2020 year in the ScholarIQ index.

What is the open-access status of Efficacy of Immune Checkpoint Inhibitors in Lung Sarcomatoid Carcinoma?

ScholarIQoa status

Efficacy of Immune Checkpoint Inhibitors in Lung Sarcomatoid Carcinoma has bronze oa status in the ScholarIQ index.

What is the DOI of Efficacy of Immune Checkpoint Inhibitors in Lung Sarcomatoid Carcinoma?

ScholarIQdoi

The DOI for Efficacy of Immune Checkpoint Inhibitors in Lung Sarcomatoid Carcinoma is on the source record.

What is the PMID of Efficacy of Immune Checkpoint Inhibitors in Lung Sarcomatoid Carcinoma?

ScholarIQpmid

The PMID for Efficacy of Immune Checkpoint Inhibitors in Lung Sarcomatoid Carcinoma is on the source record.

What is the OpenAlex record for Efficacy of Immune Checkpoint Inhibitors in Lung Sarcomatoid Carcinoma?

ScholarIQopenalex

The OpenAlex for Efficacy of Immune Checkpoint Inhibitors in Lung Sarcomatoid Carcinoma is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial